These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Peripheral neuropathy in an adolescent treated with linezolid. Linam WM; Wesselkamper K; Gerber MA Pediatr Infect Dis J; 2009 Feb; 28(2):149-51. PubMed ID: 19116599 [TBL] [Abstract][Full Text] [Related]
4. Linezolid-associated toxic optic neuropathy. Rucker JC; Hamilton SR; Bardenstein D; Isada CM; Lee MS Neurology; 2006 Feb; 66(4):595-8. PubMed ID: 16505322 [TBL] [Abstract][Full Text] [Related]
5. Linezolid-associated toxic optic neuropathy: a report of 2 cases. Lee E; Burger S; Shah J; Melton C; Mullen M; Warren F; Press R Clin Infect Dis; 2003 Nov; 37(10):1389-91. PubMed ID: 14583875 [TBL] [Abstract][Full Text] [Related]
6. Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases. Ferry T; Ponceau B; Simon M; Issartel B; Petiot P; Boibieux A; Biron F; Chidiac C; Peyramond D Infection; 2005 Jun; 33(3):151-4. PubMed ID: 15940417 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases. von der Lippe B; Sandven P; Brubakk O J Infect; 2006 Feb; 52(2):92-6. PubMed ID: 15907341 [TBL] [Abstract][Full Text] [Related]
19. Linezolid for the treatment of patients with [corrected] mycobacterial infections [corrected] a systematic review. Ntziora F; Falagas ME Int J Tuberc Lung Dis; 2007 Jun; 11(6):606-11. PubMed ID: 17519090 [TBL] [Abstract][Full Text] [Related]